219 related articles for article (PubMed ID: 31624109)
1. Disrupting the leukemia niche in the central nervous system attenuates leukemia chemoresistance.
Jonart LM; Ebadi M; Basile P; Johnson K; Makori J; Gordon PM
Haematologica; 2020 Aug; 105(8):2130-2140. PubMed ID: 31624109
[TBL] [Abstract][Full Text] [Related]
2. CXCR4 antagonists disrupt leukaemia-meningeal cell adhesion and attenuate chemoresistance.
Jonart LM; Ostergaard J; Brooks A; Fitzpatrick G; Chen L; Gordon PM
Br J Haematol; 2023 May; 201(3):459-469. PubMed ID: 36535585
[TBL] [Abstract][Full Text] [Related]
3. CD99 antibody disrupts T-cell acute lymphoblastic leukemia adhesion to meningeal cells and attenuates chemoresistance.
Ebadi M; Jonart LM; Ostergaard J; Gordon PM
Sci Rep; 2021 Dec; 11(1):24374. PubMed ID: 34934147
[TBL] [Abstract][Full Text] [Related]
4. The Role of the Central Nervous System Microenvironment in Pediatric Acute Lymphoblastic Leukemia.
Gossai NP; Gordon PM
Front Pediatr; 2017; 5():90. PubMed ID: 28491865
[TBL] [Abstract][Full Text] [Related]
5. Central nervous system pharmacology of antileukemic drugs.
Balis FM; Poplack DG
Am J Pediatr Hematol Oncol; 1989; 11(1):74-86. PubMed ID: 2496615
[TBL] [Abstract][Full Text] [Related]
6. The CNS microenvironment promotes leukemia cell survival by disrupting tumor suppression and cell cycle regulation in pediatric T-cell acute lymphoblastic leukemia.
Enlund S; Sinha I; Neofytou C; Amor AR; Papadakis K; Nilsson A; Jiang Q; Hermanson O; Holm F
Exp Cell Res; 2024 Apr; 437(2):114015. PubMed ID: 38561062
[TBL] [Abstract][Full Text] [Related]
7. Role of CXCR4-mediated bone marrow colonization in CNS infiltration by T cell acute lymphoblastic leukemia.
Jost TR; Borga C; Radaelli E; Romagnani A; Perruzza L; Omodho L; Cazzaniga G; Biondi A; Indraccolo S; Thelen M; Te Kronnie G; Grassi F
J Leukoc Biol; 2016 Jun; 99(6):1077-87. PubMed ID: 26931577
[TBL] [Abstract][Full Text] [Related]
8. The choroid plexus stroma constitutes a sanctuary for paediatric B-cell precursor acute lymphoblastic leukaemia in the central nervous system.
Fernández-Sevilla LM; Valencia J; Flores-Villalobos MA; Gonzalez-Murillo Á; Sacedón R; Jiménez E; Ramírez M; Varas A; Vicente Á
J Pathol; 2020 Oct; 252(2):189-200. PubMed ID: 32686161
[TBL] [Abstract][Full Text] [Related]
9. The meninges enhance leukaemia survival in cerebral spinal fluid.
Basile P; Jonart LM; Ebadi M; Johnson K; Kerfeld M; Gordon PM
Br J Haematol; 2020 May; 189(3):513-517. PubMed ID: 31930492
[TBL] [Abstract][Full Text] [Related]
10. A niche-like culture system allowing the maintenance of primary human acute myeloid leukemia-initiating cells: a new tool to decipher their chemoresistance and self-renewal mechanisms.
Griessinger E; Anjos-Afonso F; Pizzitola I; Rouault-Pierre K; Vargaftig J; Taussig D; Gribben J; Lassailly F; Bonnet D
Stem Cells Transl Med; 2014 Apr; 3(4):520-9. PubMed ID: 24493855
[TBL] [Abstract][Full Text] [Related]
11. Central nervous system involvement in acute lymphoblastic leukemia is mediated by vascular endothelial growth factor.
Münch V; Trentin L; Herzig J; Demir S; Seyfried F; Kraus JM; Kestler HA; Köhler R; Barth TFE; Te Kronnie G; Debatin KM; Meyer LH
Blood; 2017 Aug; 130(5):643-654. PubMed ID: 28550041
[TBL] [Abstract][Full Text] [Related]
12. Metabolic Reprogramming and Cell Adhesion in Acute Leukemia Adaptation to the CNS Niche.
Sharma ND; Keewan E; Matlawska-Wasowska K
Front Cell Dev Biol; 2021; 9():767510. PubMed ID: 34957100
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-8 blockade prevents activated endothelial cell mediated proliferation and chemoresistance of acute myeloid leukemia.
Vijay V; Miller R; Vue GS; Pezeshkian MB; Maywood M; Ast AM; Drusbosky LM; Pompeu Y; Salgado AD; Lipten SD; Geddes T; Blenc AM; Ge Y; Ostrov DA; Cogle CR; Madlambayan GJ
Leuk Res; 2019 Sep; 84():106180. PubMed ID: 31299413
[TBL] [Abstract][Full Text] [Related]
14. Peptides and small molecules blocking the CXCR4/CXCL12 axis overcome bone marrow‑induced chemoresistance in acute leukemias.
Pillozzi S; Bernini A; Spiga O; Lelli B; Petroni G; Bracci L; Niccolai N; Arcangeli A
Oncol Rep; 2019 Jan; 41(1):312-324. PubMed ID: 30365110
[TBL] [Abstract][Full Text] [Related]
15. Targeting autophagy to overcome chemoresistance in acute myleogenous leukemia.
Piya S; Andreeff M; Borthakur G
Autophagy; 2017 Jan; 13(1):214-215. PubMed ID: 27797294
[TBL] [Abstract][Full Text] [Related]
16. Phytochemical Modulation of Apoptosis and Autophagy: Strategies to Overcome Chemoresistance in Leukemic Stem Cells in the Bone Marrow Microenvironment.
Owen HC; Appiah S; Hasan N; Ghali L; Elayat G; Bell C
Int Rev Neurobiol; 2017; 135():249-278. PubMed ID: 28807161
[TBL] [Abstract][Full Text] [Related]
17. Combination intrathecal therapy for meningeal leukemia: two versus three drugs.
Sullivan MP; Moon TE; Trueworthy R; Vietti TJ; Humphrey GB; Komp D
Blood; 1977 Sep; 50(3):471-9. PubMed ID: 577889
[TBL] [Abstract][Full Text] [Related]
18. Central nervous system relapse after bone marrow transplantation for acute leukemia in first remission.
Singhal S; Powles R; Treleaven J; Horton C; Tait D; Meller S; Pinkerton CR; Mehta J
Bone Marrow Transplant; 1996 Apr; 17(4):637-41. PubMed ID: 8722368
[TBL] [Abstract][Full Text] [Related]
19. Liposomal cytarabine is effective and tolerable in the treatment of central nervous system relapse of acute lymphoblastic leukemia and very aggressive lymphoma.
Gökbuget N; Hartog CM; Bassan R; Derigs HG; Dombret H; Greil R; Hernández-Rivas JM; Huguet F; Intermesoli T; Jourdan E; Junghanss C; Leimer L; Moreno MJ; Reichle A; Ribera J; Schmid M; Serve H; Stelljes M; Stuhlmann R; Hoelzer D;
Haematologica; 2011 Feb; 96(2):238-44. PubMed ID: 20952517
[TBL] [Abstract][Full Text] [Related]
20. Low dose triptolide reverses chemoresistance in adult acute lymphoblastic leukemia cells via reactive oxygen species generation and DNA damage response disruption.
Zhao H; Shi P; Deng M; Jiang Z; Li Y; Kannappan V; Wang W; Li P; Xu B
Oncotarget; 2016 Dec; 7(51):85515-85528. PubMed ID: 27888802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
